ABSTRACT: Apicomplexan parasites rely on calcium as a second messenger to regulate a variety of essential cellular processes. Calciumdependent protein kinases (CDPK), which transduce these signals, are conserved among apicomplexans but absent from mammalian hosts, making them attractive targets for therapeutic intervention. Despite their importance, the signaling pathways CDPK regulate remain poorly characterized, and their protein substrates are completely unknown. In Toxoplasma gondii, CDPK1 is required for calcium-regulated secretion from micronemes, thereby controlling motility, invasion, and egress from host cells. CDPK1 is unique among parasite and mammalian kinases in containing glycine at the key "gatekeeper" residue, which results in an expanded ATP-binding pocket. In the present study, we use a synthetic ATPγS analogue that displays steric complementarity to the ATP-binding pocket and hence allows identification of protein substrates based on selective thiophosphorylation. The specificity of this approach was validated by the concordance between the identified phosphorylation sites and the in vitro substrate preference of CDPK1. We further demonstrate that the phosphorylation of predicted substrates is dependent on CDPK1 both in vivo and in vitro. This combined strategy for identifying the targets of specific protein kinases provides a platform for defining the roles of CDPKs in apicomplexans.
A picomplexan parasites cause prevalent and deadly human infections, with up to a quarter of the world's population chronically infected with T. gondii 1 and nearly a million deaths annually due to malaria, caused by Plasmodium spp.
2 Their divergence from model organisms, combined with their strict parasitic lifestyle, has limited our understanding of apicomplexans and hindered the identification of novel therapeutic targets. Calcium-dependent protein kinases (CDPKs) have garnered significant attention in recent years because of their importance to parasite biology and their absence from mammalian hosts. 3 Host cell invasion by apicomplexan parasites depends on gliding motility, which relies on apically secreted adhesins for substrate-dependent forward movement. 7 Adhesins are translocated via actomyosin motor complexes anchored in a network of cisternae under the plasmalemma, called the inner membrane complex. 8 Elevated cytosolic calcium triggers release of adhesins from small, elongated vesicles, called micronemes. 9 Cytosolic calcium has been observed to oscillate during motility, 10 and movement is effectively blocked by calcium chelators. 9 Calcium signaling in mammalian cells typically leads to downstream activation of protein kinase C (PKC) and calcium/ calmodulin dependent protein kinase (CaMK). 11, 12 In contrast, apicomplexans lack PKC and have few CaMK isoforms and instead express an expanded family of calcium-dependent protein kinases (CDPKs). 3, 13 Composed of a serine/threonine kinase domain followed by a C-terminal regulatory domain consisting of four EF hands, CDPKs are found in apicomplexans as well as plants and ciliates. 14 In Plasmodium spp. many CDPKs are dispensable for growth in erythrocytes and have been knocked out leading to defects in later developmental stages including male gamete exflagellation, 15 ookinete motility, 16, 17 and sporozoite recognition of hepatocytes. 18 More recently, conditional expression of CDPK5 in P. falciparum demonstrated its role in egress from erythrocytes. 6 Taken together, these studies demonstrate that CDPKs play central roles in parasite biology, although their precise molecular functions have yet to be established. Using a conditional knockout, we have previously demonstrated that T. gondii calcium-dependent protein kinase 1 (TgCDPK1) is required for microneme secretion. 4 However, none of the phosphorylated proteins known to regulate secretion in animals, such as rabphilin or synapsin, 19 are readily identifiable in apicomplexans by BLAST searches, 20 and the mechanism for TgCDPK1 regulation of microneme secretion remains unknown.
Unlike any other known parasite or mammalian kinase, TgCDPK1 harbors a glycine at a position in the ATP-binding pocket, termed the gatekeeper, which forms a deep hydrophobic pocket. 21 We and others have exploited this feature to inhibit TgCDPK1 in vitro and in vivo, using bulky pyrazolo [3,4-d] pyrimidine (PP) derivatives originally designed to inhibit yeast or mammalian kinases that were engineered to contain a small gatekeeper. 4,5,21−23 Mutation of the gatekeeper residue of TgCDPK1 to a methionine prevents inhibition by PP analogues, demonstrating the specificity of these compounds in parasites. 4 In the current study, we used bulky ATPγS analogues 24 to detect and identify the protein substrates of TgCDPK1. This work serves to emphasize the potential of chemical genetics in investigating both the phenotypes and cellular pathways regulated by essential kinases in parasites.
■ RESULTS AND DISCUSSION
TgCDPK1 Thiophosphorylates Heterologous Substrates. Bulky ATP analogues have previously been used to specifically label the targets of kinases engineered to contain small gatekeepers. 25 By replacing the γ-phosphate of these artificial ATP-analogues with a thiophosphate, the targets of such kinases can be isolated on the basis of chemistry specific to the thiol group. 24, 26 To utilize this strategy to study the targets of TgCDPK1, we incubated recombinant CDPK1 harboring either the wild type glycine or a methionine gatekeeper with dephosphorylated myelin basic protein (dMBP), a heterologous substrate. The following bulky ATP analogues were compared for labeling:
. Thiophosphorylation of dMBP was detected following alkylation with p-nitrobenzyl mesylate (PNBM) using an antibody that specifically recognizes alkylated thiophosphates (rabbit mAb 51-8). 24 We observed that only KTPγS was efficiently utilized by wild type TgCDPK1 to thiophosphorylated dMBP in a calcium-dependent manner ( Figure 1, panels a,b) . The ability of TgCDPK1 to utilize KTPγS depended on the presence of a glycine gatekeeper (CDPK1 G ) since the mutant kinase (CDPK1 M ) was unable to thiophosphorylate dMBP ( Figure 1, panel a) , despite the fact that this mutant enzyme is fully active when using ATP. 4, 5 On the basis of these results, KTPγS was chosen for subsequent experiments to specifically identify TgCDPK1 substrates.
Visualizing CDPK1 Targets in T. gondii Lysates. To detect targets of TgCDPK1 in parasite lysates, we compared thiophosphorylation in wild type parasites (CDPK1 G ) and a mutant TgCDPK1 allele with a methionine at the gatekeeper position (CDPK1 M ). 5 Parasite lysates were incubated in a reaction buffer containing KTPγS and either 0 or 10 μM free calcium, alkylated with PNMB, and resolved by SDS-PAGE, followed by Western blotting for thiophosphorylation or GRA1, a dense granule protein used as a loading control. Thiophosphorylated proteins were significantly more abundant in the lysates from the strain harboring CDPK1 G ( Figure 2 , panel a), and as expected this reaction was only seen in the presence of calcium ( Figure 2, panel a) .
To isolate targets of TgCDPK1 from the complex lysate, we used the rabbit mAb 51-8 to immunoprecipitate thiophosphorylated proteins following alkylation. Lysates from CDPK1 M expressing parasites were used as a control for nonspecific labeling. The immunoprecipitated proteins were resolved by SDS-PAGE and stained with SYPRO Ruby (Invitrogen). A number of bands were specifically detected in the CDPK1 G sample, potentially representing targets of TgCDPK1 (Figure 2, panel b) . In particular, two bands between 100 and 150 kDa were observed by both immunoprecipitation and when probing the entire lysate for thiophosphorylated proteins. However, given the complexity of the thiophosphorylation patterns, we opted for a global approach rather than analyzing specific bands.
Identifying Proteins Thiophosphorylated by TgCDPK1. Two strategies have been described to enrich for thiophosphorylated targets and to enable their identification by mass spectrometry (Figure 3 , panel a). As described above, the monoclonal antibody specific for the thiophosphorylation modification was used to immunoprecipitate target proteins. 24 Alternatively, the samples are digested to yield peptides and captured covalently with an iodoacetyl resin, which immobilizes peptides with free sulfhydryl groups. 26 Thiophosphorylated peptides are then removed from the resin by oxidation, leaving a phosphate group on the previously thiophosphorylated residue. This latter approach permits identification of the protein and the site of thiophosphorylation. Both strategies were performed for the CDPK1 G and CDPK1 M samples, which were then submitted to MS/MS analyses. We restricted our analysis to proteins identified on the basis of at least two peptides, each with an identification probability greater than 90%, within the combined set of four samples. On the basis of these criteria, 114 proteins were identified among all four samples ( Figure 3 , panel b). In the immunoprecipitation experiment, 68 proteins were identified uniquely in the CDPK1 G sample, 27 proteins were identified in both samples, and only 9 were identified exclusively in the CDPK1 M sample. Fewer proteins overall were identified by the direct peptide capture strategy, but all of them carried phosphorylation of either a serine or a threonine. By the latter method, 19 proteins were identified exclusively in the CDPK1 G sample, a single protein was found in both samples, and none were found only in the CDPK1 M sample (a complete list of identified proteins can be found in Supplementary Table 1 ). Given the low background observed by Western blotting in the CDPK1 M strain ( Figure 2, panel a) , we speculate that many of the proteins identified for both strains in the immunoprecipitation experiment are likely enriched independently of thiophosphorylation or represent abundant proteins that are common contaminants of immunoprecipitations. In contrast the covalent capture of thiophosphorylated peptides allowed more stringent removal of background peptides, which is reflected in the data obtained by this approach. In addition to their identity, we also identified 30 distinct phosphorylation sites among the 19 proteins identified by peptide capture, which provided information about the substrate preference of TgCDPK1.
Peptide Preference of TgCDPK1. To explore the peptide substrate preference of TgCDPK1, we performed in vitro phosphorylation assays using a positional-scanning peptide array. 28 TgCDPK1 showed a strong preference for serine over threonine, for arginine at the −3 position, and for hydrophobic residues at the −5 position (Figure 4, panel a) . The values from the peptide array were use to generate a protein profile, which was used to assess the preference of TgCDPK1 for each serine or threonine within the proteins identified in the CDPK1 G sample by peptide capture. Although the maximum scores varied among the different proteins, we consistently observed that the highest scoring sites within each protein were those identified in the peptide capture strategy. To quantify this effect, we compared the rank within a given protein of the sites identified as thiophosphorylated by TgCDPK1 to the rank of phosphorylation sites previously identified in a global phosphoproteome. 29 This analysis demonstrated a highly significant enrichment of sites preferred by TgCDPK1 among the peptides identified by thiophosphorylation and direct peptide capture in the present study ( Figure 4, panel b) . The similarity between the site preference of TgCDPK1 in the peptide array and that predicted by the thiophosphorylation sites is further evidenced by the similar sequence-based WebLogos generated from each data set (Figure 4 , panels c and d). These observations further support the specificity of the peptide capture strategy for target identification and suggest that substrate preference by the kinase is retained under the conditions tested. They also suggest that this strategy may be useful to further define possible phosphorylation sites of candidate TgCDPK1 substrates, including those identified in the IP strategy, on the basis of the degree to which different sites match the predicted motif.
Two Conserved Proteins Are Thiophosphorylated by TgCDPK1. A total of six proteins were identified in both CDPK1 G data sets while being absent from the CDPK1 M data sets (Table 1) . Of these six proteins, only one of them had been previously studied in a report that described it as a dynaminrelated protein, DrpB (TGGT1_064650). 30 The other five proteins were annotated as hypothetical 20 and had no conserved protein domains. One of the five hypothetical proteins was identified by its type II strain ME49 gene ID due to its absence from the type I strain GT1 annotation (TGME49_005320), likely due to misannotation. Comparison of the two genomes revealed that both predicted proteins contain a central portion of repeats with a periodicity of 28 residues and that the GT1 protein is predicted to contain an additional three repeats (data not shown). Because many of the phosphorylated peptides identified came from these repeats, TGME49_005320 will be called, henceforth, phosphorylated repeat protein (PRP).
As calcium regulation of microneme secretion is a conserved feature in apicomplexans, we predicted that crucial targets of TgCDPK1 would also be conserved, at least within the phylum. DrpB had been previously reported to be involved in the biogenesis of secretory organelles, which are lost following expression of a dominant negative mutant. 30 Other than DrpB, which had clear homologues in all apicomplexan genomes, only PRP was conserved across all apicomplexans. 31 Despite being divergent at their N-termini, all possessed a series of 28-residue repeats in their C-termini. On the basis of their conservation among apicomplexan genomes, we decided to generate parasite strains expressing tagged versions of PRP or DrpB in order to test if they are targets of TgCDPK1 in vivo. We generated transgenic parasites expressing C-terminally Ty-tagged PRP or N-terimally tagged DrpB ( Figure 5, panel a) . Immunofluorescence analysis revealed that PRP was distributed in punctate structures throughout the cell, while DrpB was concentrated in the apical end, as previously reported. 30 To determine whether TgCDPK1 was required for the thiophosphorylation, we compared the conditional knockout (cKO) of TgCDPK1 with the same strain expressing tagged versions of either DrpB or PRP. Lysates from the different strains were incubated in a reaction buffer containing KTPγS, and the putative targets were immunoprecipitated with the Tytag. Comparable amounts of both DrpB and PRP were immunoprecipitated, irrespective of the presence of anhydrotetracycline (ATc), which suppresses TgCDPK1 expression in the cKO. However, robust thiophosphorylation was detected only when strains were grown without ATc and therefore expressed TgCDPK1 ( Figure 5, panel c) . This result confirms that both DrpB and PRP are thiophosphorylated in a TgCDPK1-dependent manner, validating our strategy for identifying thiophosphorylated proteins.
TgCDPK1 Regulates DrpB Phosphorylation in Vivo. To confirm whether these observations could be extended to phosphorylation in vivo, we examined the phosphorylation of DrpB in the TgCDPK1 conditional knockout line labeled with [ 32 P] orthophosphate and grown with or without ATc. Labeled parasites were stimulated with ethanol, which raises intracellular calcium and stimulates microneme secretion. 9 Equal amounts of DrpB were immunoprecipitated under all conditions. However, the amount of radiolabel incorporated into DrpB significantly increased in parasites expressing TgCDPK1 that had been stimulated to secrete ( Figure 6, panel a) . In contrast, when TgCDPK1 expression was suppressed by growth in ATc, labeling of DrpB was significantly reduced, regardless of stimulation ( Figure 6, panel a) . These differences were replicated in three independent experiments, demonstrating that DrpB is phosphorylated in a TgCDPK1-dependent manner during microneme secretion ( Figure 6, panel b) . Both full-length and C-terminally truncated proteins were captured in pull-downs (Figure 6 ), similar to studies with DrpB and the related DrpA. 30, 32 The observation that the truncated forms of the protein were neither thiophosphorylated ( Figure  5 , panel c) nor phosphorylated in vivo ( Figure 6, panel a) indicates that modification occurs in the C terminus of DrpB, consistent with the location of sites identified by peptide capture (Table 1) . This region constitutes a C-terminal extension following the GTPase effector domain, which is found in all apicomplexan DrpB homologues but not in the related DrpA, 30 suggesting that it might be a regulatory site specific to DrpB.
Conclusions and Implications. The atypical ATP-binding pocket of TgCDPK1 provides a chemical handle to distinguish its activity from that of other parasite and mammalian kinases. A bulky ATP analogue that is accommodated by the enlarged ATP-binding pocket 24 was used to specifically thiophosphorylate and identify protein substrates of TgCDPK1. This approach provides an unbiased method for identifying the targets of TgCDPK1, which has previously been shown to control microneme secretion during motility. 4 How the various targets of TgCDPK1 identified here might affect these cellular processes remains the focus of future studies. Quantitative MS approaches will also serve to confidently identify lower abundance targets, thus expanding the known repertoire of TgCDPK1 targets.
Two of the targets identified here have homologues in other apicomplexans, and we demonstrate their direct thiophosphorylation by TgCDPK1. One of these substrates, DrpB, had been previously implicated in the biogenesis of secretory organelles. Using radiolabeled parasites we were able to show that DrpB is phosphorylated in vivo in a TgCDPK1-dependent manner, and its phosphorylation increases when microneme secretion is triggered. Although dynamins and related proteins are typically thought of as mediating endocytosis, evidence is accumulating for a more complex role in the regulation of the vesicular trafficking dynamics, regulating the rates of vesicle recycling 33 and the size of fusion pores, 34 which may significantly restrict both the quantity and size of exocytosed material. Although further work will be needed to determine the function of DrpB phosphorylation, it is possible that the previously identified role in biogenesis of secretory organelles is only one of the functions of DrpB 32 and that it also plays an important role in microneme secretion.
The strategies outlined here may also be useful for comparing CDPK function across different apicomplexans, since the homologues of TgCDPK1 in Cryptosporidium spp. also harbor glycine gatekeeper residues and are potentially capable of utilizing KTPγS. Moreover, this strategy could be extended to other CDPKs to identify their substrates and thereby define the pathways they control. Although other CDPKs are not directly amenable to this strategy, they can be engineered to gain sensitivity to both PP analogues and bulky ATP substrates. For example, when the endogenous allele of TgCDPK1 is replaced with one carrying a methionine gatekeeper, it provides a background for sensitizing other kinases to the PP analogues, thereby allowing study of the phenotypes they regulate. 5 In such an engineered background, it should also be possible to label the specific targets of other CDPKs using KTPγS to capture thiophoshorylated substrates, as has been done in other organisms. 35, 36 Consequently, the approaches presented here provide a powerful opportunity for defining the signaling pathways regulated by CDPKs within and across different apicomplexan parasites.
■ METHODS
Parasite Growth and Selection. T. gondii tachyzoites were grown in human foreskin fibroblasts (HFF) cultured in complete medium [Dulbecco's Modified Eagles Medium (DMEM; Invitrogen) supplemented with 10% (v/v) tetracycline-free FBS (HyClone), 2 mM glutamine, 10 mM HEPES (pH 7.5), and 20 μg mL −1 gentamicin], as previously described. 4 When noted, parasites were selected by growth in complete medium containing ATc (1 μg mL −1 ; Clontech) or pyrimethamine (3 μM; Sigma).
Plasmid and Strain Generation. The TgCDPK1 cKO was described previously. 4 The Δku80Δhxgprt background, referred to in this study as CDPK1 G (provided by V. Carruthers, University of Michigan, USA), was used as a control and to generate the CDPK1 M strain, as previously described. 5 The tagging constructs for PRP-Ty and Ty-DrpB were directionally cloned PacI to AscI into pLIC-YFP-HXGPRT (provided by V. Carruthers, University of Michigan, USA). The 5′-UTR of DrpB was amplified (primers: 5′GCG TTA ATT AAC CTC TTG CCG GAG C and 5′GCG GCC GCG CCG AGA CGT CCT CGC GTT TGC CGT CAT CGA GCG GGT CCT GGT TCG TGT GGA CCT CCA TCT GCC GAA GAT TTC GGA GG) from RH genomic DNA and spliced at a NotI site with the DrpB cDNA amplified (primers: 5′GAC GGC AAA CGC GAG GAC GTC and 5′ GCG GGC GCG CCT TAG TCG CTG AAC AGC GGA TTG TTC) from a library generated with the SMART cDNA synthesis kit (Clontech). The PRP 5′-UTR was amplified from RH genomic DNA (primers: 5′GCG TTA ATT AAT GCA GCT TCG TGC GCA GCT CGA AG and 5′CAC TGT TAT CCT CTA TTT TGA G) and spliced at a SacI site with the PRP cDNA amplified (primers: 5′ATT CTG CTC CAG CGG TAG CGT G and 5′GCG GGC GCG CCT TAA TCG AGC GGG TCC TGG TTC GTG TGG ACC TCC TCT TCG TCA TCA TCT TCG TCC G) from the library described above.
Stable lines expressing the tagged constructs were generated by selecting the transfected pool with the appropriate drug and isolating individual clones by limiting dilution. Clonal lines were maintained under pyrimethamine selection to prevent loss of the tagged alleles.
Protein Purification and Kinase Assays. Full-length TgCDPK1 was cloned and expressed as previously described. 4 Reactions were performed in a 20 μL volume containing 0.5 μg enzyme, 2 μg dMBP (Millipore), 0.005% Tween-20 (v/v), 2 mM K 2 EGTA or 2 mM Ca 2+ -EGTA, 10 mM MgCl 2 , 1 mM analogue indicated (BioLog), 20 mM HEPES pH 7.5. Thiophosphorylation was allowed to proceed for 30 min at 30°C. Laemmli sample buffer was added to each reaction and before resolving by SDS-PAGE and blotting. Total protein was imaged with SYPRO Ruby protein stain (Invitrogen) according to manufacturer's instructions.
Thiophosphorylation and Target Identification. Freshly lysed parasites were washed twice with ice-cold PBS and kept on ice until the kinase reactions were performed. Approximately 5 × 10 8 parasites were used in a final reaction volume of 200 μL. Reactions were performed in 1X D-PBS (Gibco) containing 2 mM K 2 EGTA or 2 mM CaEGTA (Molecular Probes), 10 mM MgCl 2 , 1% (v/v) NP-40, 1 mM GTP, 100 μM ATP, 50 μM KTPγS, 1X Phosphatase Inhibitor Cocktails I and II (EMD), and a protease inhibitor cocktail (E64, 1 μg mL −1 ; AEBSB, 10 μg mL
; TLCK, 10 μg mL −1 ; leupeptin, 1 μg mL −1 ; Sigma). Thiophosphorylation reactions were allowed to proceed for 30 min at 37°C. Debris was removed by centrifugation at 20,000g, 10 min, 4°C. Reactions were stopped by adding 4 mM EGTA, and alkylation was performed with 1 mM PNBM (Epitomics) for 2 h at RT. At this point samples for Western blotting were combined with Laemmli sample buffer and boiled.
Immunoprecipitation (IP) of thiophosphorylated proteins was performed as previously described. 24 In brief, PNBM was removed by buffer exchange with PD-10 columns (GE Healthcare), eluting proteins in an IP buffer containing 75 mM NaCl, 1% (v/v) NP-40, 1 mM EGTA, and 20 mM HEPES pH 7.5. Each sample was immunoprecipitated with 10 μg rabbit anti-thiophosphate ester (RmAb 51-8; Epitomics) immobilized on Protein G sepharose (Pierce). Following extensive washes with IP buffer, proteins were eluted from the beads by treating them with 20 mM DTT and 1% (v/ v) RapiGest (Waters). A portion of the eluted proteins were analyzed by SDS-PAGE and stained with Oriole fluorescent gel stain (Bio Rad), according to manufacturer's instructions. The remaining samples were analyzed by mass spectrometry as described below.
Isolation of thiophosphorylated peptides was performed with samples that were not alkylated, according to the published protocol. 26, 37 In brief, samples were digested with trypsin and added to 100 μL of iodoacetyl-agarose beads (SulfoLink gel; Pierce) in 100 μL of 50% (v/v) acetonitrile. Following overnight incubation, rotating in the dark, the beads were loaded into a disposable column and washed with 2 mL each of water, 5 M NaCl, 50% (v/v) acetonitrile, and 5% (v/v) formic acid in water. Peptides were eluted with 500 μL of a 1 mg mL −1 solution of Oxone (Sigma) and concentrated with C 18 Ziptips. Samples were analyzed by LC−MS/MS with an LTQOrbitrap Velos, with data searched using the ToxoDB 6.1 database of T. gondii proteins. Mass spectrometry was performed at the Danforth Plant Science Center's Proteomics & Mass Spectrometry Facility (St. Louis, MO). Data analysis, performed using Scaffold (Proteome Software), was restricted to proteins for which at least two spectra had been assigned with a probability greater than 90% and which had been identified with at least two peptides in the combined set of samples. This included proteins identified with a single phosphorylation site in the peptide capture approach, as long as a different peptide had been identified in the IP experiment and at least two spectra had been assigned to the phosphopeptide.
Sequence Analysis. To determine protein homology between different apicomplexan genome, we used OrthoMCL DB version 5, as previously described. 31 Motif Analysis. The sequence preference of TgCDPK1 was measured by phosphorylating a positional scanning peptide array as previously described 28 for 2 h at 30°C with 1 ng mL −1 recombinant TgCDPK1 in 50 mM HEPES, pH 7.4, 10 mM MgCl 2 , 2 mM Ca-EGTA, 0.1% (v/v) Tween 20, 50 μM [γ-
33 P]-ATP (33 μCi mL −1 ). The normalized values from the peptide array were used to create a Gribskov protein profile suitable for use with Prophet available from EMBOSS. 38 Each of the proteins identified in the peptide capture experiment was searched using the TgCDPK1 profile to determine the rank preference of different 10-letter peptides along the protein, centered on all possible Ser and Thr residues. Data for other phosphorylation sites present in these proteins was based on the published T. gondii global phosphoproteome 29 and obtained from ToxoDB. 20 The TgCDPK1 profile and the 10-letter peptides carrying the sites identified as thiophosphorylated were submitted to WebLogo, 39 to generate the visual representations of the preference motifs.
Immunofluorescence Microscopy. Immunofluorescence staining was performed as described previously 40 following permeabilization with 0.1% (w/v) saponin (Sigma) with mouse-anti-Ty (mAb BB2) 41 and rabbit anti-ALD1, 42 followed by Alexa488-goat anti-mouse IgG (Invitrogen) and Alexa594-goat anti-rabbit IgG (Invitrogen). Images were acquired in a Zeiss Axioskop fluorescence microscope equipped with a 63X 1.3 numerical aperture lens and an AxioCam MRm camera (Carl Zeiss).
Immunoprecipitation and Western Blotting. Immunoprecipitation of Ty-tagged proteins was performed following thiophosphorylation and alkylation as described above. Protein G sepharose (Pierce) was bound to mouse-anti-Ty (mAb BB2) 41 1 h, washed with IP buffer, and incubated with samples overnight at 4°C. Following extensive washes with IP buffer, Laemmli sample buffer containing 2-mercaptoethanol (3% final concentration) was added to each sample, before boiling for 10 min.
Parasite lysates (∼10 7 cells per lane) were resolved by SDS-PAGE, transferred to nitrocellulose membranes, and blotted with rabbit antiTgALD1, rabbit anti-thiophosphate ester (RmAb 51-8; Epitomics), mouse anti-Ty (mAb BB2), 41 or mouse anti-GRA1 (mAb Tg17-43, kindly provided by Marie France Cesbron, Genoble, France). The signals were detected using IRDye 680CW conjugated donkey antirabbit IgG (LI-COR Biosciences) and IRDye 800CW conjugated goat anti-mouse IgG (LI-COR Biosciences) on the Odyssey infrared imager (LI-COR Biosciences). Images were processed and analyzed using the Odyssey infrared imaging system software.
Radiolabeling Assays. For in vivo labeling, extracellular parasites were incubated in phosphate-free DMEM (Gibco) with 1 mCi [ 32 P] orthophosphate (specific activity, 8500 Ci mmol −1 ; Perkin-Elmer) for 1 h at 37°C, 5% CO 2 . Labeled parasites were resuspended in media alone or supplemented with 3% (v/v) FBS and 2% (v/v) EtOH and incubated for 5 min at 37°C. Cells were resolved by SDS-PAGE and Western blotted, following the procedures above. Radiolabel was imaged with an FLA5000 phosphorimager (Fuji).
